Ray Dalio acquired 19.8 Thousand Sarepta Therapeutics shares worth $343 Thousand. That's 0.00% of their equity portfolio (586th largest holding). The first Sarepta Therapeutics trade was made in Q1 2021. Since then Ray Dalio bought shares six more times and sold shares on eight occasions. The investor's estimated purchase price is $2.19 Million, resulting in a loss of 84%.